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In Brief
RECQ1 helicase, a proposed target for
cancer therapy, unwinds or branch
migrates key intermediates of DNA repair
and replication. Here, Banerjee et al.
show that RECQ1 governs RPA
recruitment in the context of replication
dynamics in vivo to suppress DNA
damage and preserve genomic stability.
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Three (BLM, WRN, and RECQ4) of the five human
RecQ helicases are linked to genetic disorders char-
acterized by genomic instability, cancer, and acceler-
ated aging [1]. RECQ1, the first human RecQ helicase
discovered [2–4] and the most abundant [5], was
recently implicated in breast cancer [6, 7]. RECQ1 is
an ATP-dependent DNA-unwinding enzyme (heli-
case) [8, 9] with roles in replication [10–12] and DNA
repair [13–16]. RECQ1 is highly expressed in various
tumors and cancer cell lines (for review, see [17]),
and its suppression reduces cancer cell proliferation
[14], suggesting a target for anti-cancer drugs.
RECQ1’s assembly state plays a critical role inmodu-
lating its helicase, branch migration (BM), or strand
annealing [18, 19]. The crystal structure of truncated
RECQ1 [20, 21] resembles that of E. coli RecQ [22]
with two RecA-like domains, a RecQ-specific zinc-
binding domain and a winged-helix domain, the latter
implicated inDNAstrandseparation andoligomer for-
mation. In addition, a conserved aromatic loop (AL) is
important for DNA unwinding by bacterial RecQ [23,
24] and truncatedRECQ1 helicases [21]. To better un-
derstand the roles of RECQ1, twoALmutants (W227A
and F231A) in full-length RECQ1 were characterized
biochemically and genetically. The RECQ1 mutants
were defective in helicase or BM but retained DNA
binding, oligomerization, ATPase, and strand anneal-
ing. RECQ1-depleted HeLa cells expressing either AL
mutant displayed reduced replication tract length,
elevated dormant origin firing, and increased dou-
ble-strand breaks that could be suppressed by exog-
enously expressed replication protein A (RPA). Thus,
RECQ1governsRPA’s availability in order tomaintain
normal replication dynamics, suppress DNAdamage,
and preserve genome homeostasis.
RESULTS
Biochemical Characterization of RECQ1 Aromatic Loop
Mutants
Two invariant aromatic loop (AL) residues, tryptophan (W) 227
and phenylalanine (F) 231, located within the helicase core2830 Current Biology 25, 2830–2838, November 2, 2015 ª2015 Elsevdomain of full-length RECQ1 were replaced with alanine (A) (Fig-
ures 1A and S1A). Electrophoretic mobility shift assays (EMSAs)
demonstrated the purified recombinant mutant RECQ1 proteins
were proficient in DNA binding (Figures 1B, 1C, and S1B). Km
values for ATP hydrolysis by RECQ1-W227A and RECQ1-
F231A were comparable to RECQ1-WT, suggesting normal
ATP binding (Figure 1D). Turnover rate constants for ATP hydro-
lysis (kcat) were reduced 1.6-fold for RECQ1-W227A and 2.0-fold
for RECQ1-F231A (Figure 1D). Keff values for ATP hydrolysis as a
function of DNA effector concentration for the RECQ1 proteins
were comparable (Figure 1D), consistent with their similar Kd
values. The relatively modest effects of either AL substitution
on RECQ1 DNA binding and ATPase led us to ask whether
RECQ1 unwinding (helicase) or branch migration (BM) were
affected. Both W227A and F231A showed minimal unwinding
activity on a forked duplex (19 bp) DNA substrate efficiently
unwound by RECQ1-WT (Figures 1E and S1C).
RECQ1 plays an important role in homologous recombination
(HR) repair [8, 14, 25]; therefore, we characterized the effect
of RECQ1 AL mutations on BM of HR DNA intermediates. Both
AL mutations almost completely eliminated RECQ1’s ability to
resolve a closed mobile D loop (Figures 1F and S1D) or open
three-stranded BM structure (Figures S1F and S1G). The
RECQ1 mutants displayed reduced but detectable BM activity
on a four-stranded HJ substrate (Figures 1G and S1E). Thus,
despite fairly modest effects of AL mutations on DNA binding
and ATPase, AL integrity is critical for RECQ1-catalyzed BM
and helicase activity.
RECQ1 AL Mutants Retain Strand Annealing and
Oligomerization
RECQ1, like other RecQ helicases, anneals complementary
single-stranded DNA molecules in an ATP-regulated manner
[8]. RECQ1-W227A annealing was very similar to RECQ1-WT
(Figures 1H, S1H, and S1I). RECQ1-F231A also performed
strand annealing; however, maximal product formation was
reduced. Kinetic analysis of RECQ1 strand annealing kinetics
correlated with protein titrations (Figure S1J). Strand annealing
by RECQ1-W227A or RECQ1-F231A was inhibited by ATPgS
in a manner comparable to RECQ1-WT (Figure 1H), suggesting
ATP binding induced a conformational change in the AL mutants
as observed for RECQ1-WT [8, 18], consistent with their similar
Km values for ATP hydrolysis (Figure 1D).
ATP binding affects not only RECQ1 conformational state [8]
but also oligomerization [18]. In the presence of ATP (1 mM),
RECQ1 was observed to shift from a tetramer capable of strand
annealing to a dimer with optimal helicase activity [19]. Theseier Ltd All rights reserved
Figure 1. Biochemical Analysis of Purified Recombinant Human RECQ1 Proteins
(A) Schematic of human RECQ1 showing conserved domains and helicase core signaturemotifs. The conserved aromatic-rich sequence betweenmotifs II and III
is shown with a sequence alignment of the five human RecQ helicases. The two invariant aromatic amino acids and corresponding amino acid substitutions in
RECQ1 are indicated in pink and blue, respectively (left). Coomassie-stained SDS polyacrylamide gel showing recombinant human RECQ1 proteins purified from
insect cells (right).
(B) Autoradiogram showing representative gel from EMSA experiments with RECQ1 proteins (0.15, 0.31, 0.62, 1.25, 2.5, 5, 10, and 20 nM monomer) incubated
with a forked 19-bp duplex DNA substrate.
(C) Apparent dissociation constant values (Kd) estimating binding affinities of RECQ1 proteins for the forked duplex substrate.
(D) Kinetic constants for ATP hydrolysis by RECQ1 proteins.
(E) Autoradiogram showing representative native polyacrylamide gel from helicase assays with RECQ1 proteins (0.15, 0.31, 0.62, 1.25, 2.5, 5, 10, 20, and 40 nM
monomer) and the 19-bp forked duplex DNA substrate.
(F) Autoradiogram showing representative native polyacrylamide gel from BM assays with RECQ1 proteins (25, 50,100, and 200 nM monomer) and mobile
three-stranded D loop DNA substrate.
(G) Autoradiogram showing representative native polyacrylamide gel from BM assays with RECQ1 proteins (0.62, 1.25, 2.5, 5, 10, and 20 nM monomer) and the
four-stranded HJ DNA substrate.
(H) Autoradiogram showing representative native polyacrylamide gel from strand annealing assays with RECQ1 proteins (1.25, 2.5, 5, 10, 20, and 40 nM
monomer) and complementary single-stranded oligonucleotides in the absence or presence of 1 mM ATPgS as indicated.
(I and J) Size exclusion chromatogram showing distribution of purified RECQ1 proteins incubated in the absence (I) or presence (J) of 1 mM ATP.
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observations led us to ask whether the RECQ1 AL mutant pro-
teins behaved in a similar ATP-regulated manner. Size exclusion
chromatography with 1 mM ATP present demonstrated compa-
rable shift of wild-type and mutant RECQ1 proteins from two
species of 400 kD and 200 kD to a single species of interme-
diate size (270 kD; Figures 1I and 1J). We conclude that the AL
mutations in full-length RECQ1 do not perturb ATP-regulated
oligomerization.
RECQ1 AL Mutations Interfere with Normal Cellular
Replication
Approximately 75% of endogenous RECQ1 was depleted
by RECQ1-siRNA, and plasmid-based expression for either
RECQ1-W227A or RECQ1-F231A in RECQ1-depleted cells
was comparable to endogenous RECQ1, whereas exogenous
expression of RECQ1-WT was slightly less than endogenous
RECQ1 (Figure 2A). HeLa cells co-transfected with a control
siRNA and blank vector displayed a greater percentage of repli-
cation tracts in the range of 8–10 mm (Figures 2B and 2C).
RECQ1-depleted cells co-transfected with empty vector dis-
played much reduced tract length with the peak shifted to
2–6 mm, indicating slower replication. RECQ1-depleted cells
exogenously expressing RECQ1-WT showed a greater number
of forks with replication tract lengths in the 4–10 mm range (Fig-
ures 2B and 2C). In contrast, RECQ1-depleted cells expressing
RECQ1-W227A or RECQ1-F231A displayed replication tract
lengths similar to RECQ1-depleted cells co-transfected with
empty vector, indicating the RECQ1 AL mutants were defective
in restoring normal replication.
Slower replication causes dormant replication origin firing to
compensate for the delay [26, 27], leading us to ask whether
RECQ1 deficiency resulted in elevated dormant origin firing.
RECQ1-depleted cells co-transfected with empty vector dis-
played double the number of dormant origins fired compared
to control cells or RECQ1-depleted cells exogenously express-
ing RECQ1-WT (Figure 2D). RECQ1-depleted cells expressing
RECQ1-W227A or RECQ1-F231A showed a 2-fold increase
in dormant origins fired. Thus, expression of either RECQ1 AL
mutant failed to rescue the reduced replication fork rate and
elevated dormant origin firing characteristic of RECQ1-deficient
cells.
Based on the abnormal replication dynamics of RECQ1-
deficient cells [10, 11, 13] (current study), we asked whether
RECQ1 deficiency resulted in increased double-strand breaks
(DSB) and whether expression of the RECQ1 AL mutants could
restore this defect. RECQ1-depleted cells co-transfected with
empty vector or plasmids encoding RECQ1-W227A or RECQ1-
F231A displayed an increased percentage of cells with greater
than five 53BP1 foci compared to control cells or RECQ1-
depleted cells exogenously expressing RECQ1-WT (Figures 2E
and 2F), indicative of DSB accumulation.
Compromised DNA Damage Resistance of
RECQ1-Depleted Cells Expressing RECQ1 AL Mutants
RECQ1’s role in replication restart after exposure to the
topoisomerase inhibitor camptothecin (CPT) [11] led us to ask
whether the RECQ1 AL mutants could restore CPT resistance.
Chromatin-associated wild-type or AL mutant RECQ1 in the
CPT-treated RECQ1 transfected cell lines was comparable (Fig-2832 Current Biology 25, 2830–2838, November 2, 2015 ª2015 Elsevure 2G); however, neither RECQ1 mutant restored cellular resis-
tance to CPT (Figures 2H and 2I). BecauseCPT-induced blocked
replication forks are known to incur single-stranded and double-
stranded DNA breaks [28] and RECQ1-deficient cells are sensi-
tive to hydrogen peroxide (H2O2) that induces strand breaks and
oxidative damage [15], we tested for H2O2 sensitivity and found
that neither RECQ1 AL mutant could restore viability to the level
of control cells or RECQ1-depleted cells exogenously express-
ing RECQ1-WT (Figure 2J).
RECQ1SuppressesDormant Origin Firing andMaintains
Free RPA Pool
Dormant origin firing was shown to cause replication protein A
(RPA) recruitment to sites of nascent DNA synthesis, thereby ex-
hausting the global RPA pool, resulting in single-stranded DNA
exposure vulnerable to strand breaks [29]. This led us to investi-
gate whether RECQ1 played a role in determining RPA availabil-
ity during the DNA damage response. RPA foci were induced
upon CPT challenge in RECQ1-proficient HeLa cells (Figures
3A and S2B). However, cells depleted of endogenous RECQ1
and transfected with either blank vector or RECQ1 AL mutant
poorly formed RPA foci upon CPT exposure (Figures 3A and
S2B). Exogenous RPA expression (Figure S2A) restored forma-
tion of CPT-induced RPA foci in RECQ1-depleted cells (Figures
3B and S2B). MRE11 foci were able to form in CPT-treated
RECQ1-depleted cells, suggesting that there was not a defect
upstream of RPA (Figure 3C). In contrast, the downstream player
RAD51 poorly formed foci in CPT-treated RECQ1-deficient cells
(Figures 3D and S2C). Spontaneous 53BP1 foci were reduced
in cells overexpressing RPA in the RECQ1-depleted condition
(Figures 3E and 3F), suggesting that DNA damage accumulation
in RECQ1-deficient cells is due to RPA sequestration by nascent
DNA synthesis sites at activated dormant origins.
Dominant Negative Phenotypes Exerted by RECQ1 AL
Mutants
Given the importance of tumor suppressor heterozygosity in
cancer [30–32], we assessed whether the RECQ1 AL mutants
exerted dominant-negative effects. HeLa cells transfected with
wild-type or mutant RECQ1 expression constructs showed a
2-fold increase of RECQ1 protein compared to cells transfected
with empty vector (Figure 4A). DNA fiber analysis demonstrated
that expression of RECQ1-W227A or RECQ1-F231A in the
wild-type background resulted in shorter replication tract
lengths (Figures 4B and 4C). Consistent with slower replication,
dormant origin firing in cells expressing either RECQ1 mutant
was increased 2-fold (Figure 4D).
The abnormal replication dynamics of HeLa cells expressing
RECQ1-W227Aor RECQ1-F231A led us to examine their growth.
Cells expressing RECQ1-W227A or RECQ1-F231A displayed
greater proliferation compared to cells transfected with empty
vector and at a level comparable to cells exogenously expressing
RECQ1-WT (Figure 4E). It was reported that RECQ1 depletion
resulted in slow growth of cancer cells accompanied by reduced
DNA synthesis [14], consistent with slower fork progression;
therefore, it was surprising to find that RECQ1ALmutant expres-
sion increased cell proliferation given their negative effect on
replication tract length (Figures 4B and 4C), suggesting a
possible defect in checkpoint activation. CPT-treated HeLa cellsier Ltd All rights reserved
Figure 2. Perturbed Replication and Genomic Instability of Human Cells Expressing RECQ1-W227A or RECQ1-F231A Aromatic LoopMutant
Proteins
(A) Representative western blot from lysates of HeLa cells transfected with control siRNA or siRNA against 30 UTR of RECQ1 and an expression construct
encoding the indicated RECQ1 protein. Actin serves as a loading control.
(B) RECQ1-depleted cells (RECQ1 KD) exogenously expressing RECQ1-WT, RECQ1-W227A, or RECQ1-F231A protein were labeled with CldU or IdU indicated
by red and green tracts, respectively. Representative DNA fiber tracts from microfluidic-assisted tract analysis are shown.
(C) Statistical analysis of percentage replication forks with the indicated tract lengths (mm). At least 100 tracts were analyzed for each cell line.
(D) Percentage of dormant origins fired for indicated cell lines.
(legend continued on next page)
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expressing either RECQ1 AL mutant displayed decreased phos-
phorylated Chk1S345 (Figure 4F) and Chk1S317 or Chk2T68
(Figures S3A and S3B). Consistent with a checkpoint defect,
CPT-treated cells expressing the RECQ1 AL mutant did not
show an increased S phase population (Figure S3C).
HeLa cells expressing either RECQ1 ALmutant showed signif-
icantly greater spontaneous DNA damage compared to cells
transfected with empty vector or RECQ1-WT plasmid (Figures
4G and 4H). Moreover, RECQ1-W227A or RECQ1-F231A ex-
pressed in a wild-type RECQ1 background rendered cells
more sensitive to either CPT (Figures S3D and S3E) or H2O2 (Fig-
ure S3F), also observed for DSB induction (Figures S3G–S3J).
CPT-treated HeLa cells expressing RECQ1 AL mutants failed
to form discreet RPA foci; however, exogenous RPA expression
alleviated this effect (Figure S3K). Formation of RAD51 foci (Fig-
ure S3K), but not MRE11 foci (data not shown), was impaired by
expression of RECQ1 AL mutants, consistent with a direct effect
on free RPA pool.
Biochemical Mixing Experiments with Mutant and
Wild-Type RECQ1 Proteins
In vitro mixing experiments with RECQ1-WT and either RECQ1-
W227A or RECQ1-F231Awere performed to assay effects on HJ
resolution or forked duplex DNA unwinding. The presence of
either RECQ1 AL mutant in reaction mixtures with RECQ1-WT
inhibited unwinding of forked duplex DNA; however, inhibition
on the HJ substrate was only observed in conversion of splayed
arm product to single-stranded DNA, not HJ BM (Figures S3L–
S3S). The RECQ1ALmutants retainedHJ substrate binding (Fig-
ure S3T), consistent with their residual HJ BM activity (Figures
1G, S1E, and S3L–S3O). Taking together these and published
results [19], we conclude that either RECQ1 AL mutant protein
poisons forked duplex unwinding by RECQ1 dimer (and possibly
monomer), but not HJ BM catalyzed by RECQ1 tetramer.
DISCUSSION
Biochemical characterization of RECQ1-W227A or RECQ1-
F231A revealed a critical role of the conserved AL to couple
ATP hydrolysis to DNA BM or helicase activity. The severe
reduction of RECQ1 BM despite a modest reduction in ATPase
activity suggests that the surface-exposed AL of RECQ1 may
very well interact with single-stranded DNA during concomitant
ATPase-dependent coupled strand separation and annealing,
consistent with predictions from analysis of truncated RECQ1-
DNA crystal structures [19, 20] (Figure S1J).
The reduced replication kinetics of RECQ1 AL-mutant-
expressing cells is accompanied by increased dormant origin
firing, presumably to help them complete DNA synthesis in a
timely manner during S phase. Reduced replication rate is also
likely to contribute to elevated DSBs. Nascent DNA synthesis
at dormant origins activated as a result of slow replication fork(E) Representative 53BP1 fluorescence-staining images of indicated cell lines.
(F) Quantitative analysis of immunofluorescence data as shown in (E). Percentag
(G) Western blot showing the relative binding of RECQ1 proteins to chromatin is
(H) The indicated cell line was exposed to CPT (125 nM; 16 hr) and percent viab
(I) Indicated cell lines were exposed to 100 nM CPT for 1 hr and monitored after
(J) Cell lines were exposed to H2O2 (200 mM; 30 min), and percent viable cells w
2834 Current Biology 25, 2830–2838, November 2, 2015 ª2015 Elsevprogression in cells expressing either RECQ1 AL mutant
sequester free RPA, thereby exposing single-stranded DNA
and making it more vulnerable to damage. RECQ1-depleted
cells expressing RECQ1 AL mutant protein show increased
sensitivity to DNA damage induced by H2O2 or collision of repli-
cation forks with CPT drug-topoisomerase complexes [33, 34],
suggesting for the first time that catalytic strand separation activ-
ities of RECQ1 are required for a robust DNA damage response.
Based on the elevated sister chromatid exchange and IR sensi-
tivity of RECQ1-deficient mouse embryonic fibroblasts [13] or
human cells [14], we propose that RECQ1 supports or facilitates
HR repair of frank or replication-associated DSBs, consistent
with its ability to BM HJs [8] and D loop intermediates [25].
Furthermore, RECQ1 governs the RPA-mediated response to
replication stress to maintain chromosomal stability.
Expression of either RECQ1 AL mutant in a genetic back-
ground of wild-type RECQ1 resulted in reduced replication rate
accompanied by increased dormant origin firing, elevated
DSBs, and compromised H2O2 or CPT resistance, similar to
that observed for RECQ1-depleted cells expressing either AL
mutant. Biochemical mixing experiments demonstrated that
either RECQ1 AL mutant poisoned DNA unwinding by RECQ1-
WT, presumably by hetero-oligomerization or static mutant
RECQ1-DNA complexes. Further studies are required to ascer-
tain mechanism of helicase inhibition and dominant-negative
effects in vivo.
Our finding that cancer cells expressing helicase-defective
RECQ1 accumulate DNA damage and bypass replication check-
point suggests that RECQ1 variants may contribute to tumori-
genesis. RECQ1 overexpression is observed in glioblastomas
and ovarian cancers and suggested to play a role in tumor cell
proliferation [35–37]. Several RECQ1 polymorphisms are associ-
ated with lower pancreatic cancer survival [38], and RECQ1 is a
proposed therapeutic target and proliferative marker for head
and neck squamous cell carcinoma [39] and hepatocellular car-
cinoma [39, 40]. The growth advantage of cancer cells express-
ing catalytically defective mutant RECQ1 is most likely through
a mechanism involving checkpoint bypass distinct from that
involving overexpression of wild-type RECQ1, which probably
helps cancer cells cope with replicative lesions.
Clinically important missense mutations have been identi-
fied in helicase genes [41]. RECQ1 missense variants reside in
the core helicase domain (http://www.ncbi.nlm.nih.gov/SNP/
snp_ref.cgi?locusId=5965; Figure S3U) and adjacent to the
AL (http://exac.broadinstitute.org/gene/ENSG00000004700).
RECQ1 SNPs may contribute to tumorigenesis [42] or act as ge-
netic modifiers to influence pathogenesis, as proposed for other
DNA damage response proteins [43].
Given that CPT-induced replication blocks closely mimic the
spectra of normal spontaneously collapsed replication forks
[44], our studies are informative for understanding how RECQ1
helps cancer cells deal with endogenous replication stress.e of cells with greater than five 53BP1 foci is shown.
olated from CPT-treated cells.
le cells determined by WST-1 assay.
13 days for colony formation.
as determined by WST-1 assay.
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Figure 3. DNA Damage in HeLa Cells Expressing Catalytically Defective RECQ1 Is a Function of RPA Exhaustion
(A) Representative immunofluorescence images of RPA staining in indicated HeLa cell lines treated with either DMSO or 200 nM CPT for 30 min.
(B–E) Representative immunofluorescence images of RPA (B),MRE11 (C), RAD51 (D), and 53BP1 (E) staining in indicated HeLa cell lines treatedwith either DMSO
or 200 nM CPT for 30 min.
(F) Quantitative analysis of 53B1 staining in cells represented in (E).RECQ1directs aproductiveRPA-dependent response to endog-
enous replication stress by ensuring a normal replication rate and
suppressing dormant origin firing. Bymaintaining the global RPA
pool, RECQ1 provides cancer cells an opportunity to protectCurrent Biology 25, 2830–28exposed single-stranded DNA in periods of heightened replica-
tion stress to enable fork progression. Further work may help to
elucidate mechanisms of RECQ1 that could be targeted for inhi-
bition in anti-cancer therapies.38, November 2, 2015 ª2015 Elsevier Ltd All rights reserved 2835
Figure 4. Dominant-Negative Effects Exerted by Expression of RECQ1 Aromatic Loop Mutant Proteins
(A) Representative western blot from lysates of HeLa cells transfected with an expression construct encoding the indicated RECQ1 protein. Actin serves as a
loading control.
(B) HeLa cells exogenously expressing RECQ1-WT, RECQ1-W227A, or RECQ1-F231A protein were labeled with CldU or IdU indicated by red and green tracts,
respectively. Representative DNA fiber tracts from microfluidic-assisted tract analysis are shown for each of the cell lines.
(C) Statistical analysis of percentage replication forks with the indicated tract lengths (mm). At least 100 tracts were analyzed for each cell line.
(D) Percentage of dormant origins fired for the indicated cell lines.
(E) Graph comparing the growth pattern of HeLa cells overexpressing exogenous wild-type or either of the two RECQ1ALmutant proteins over a period of 3 days.
(legend continued on next page)
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EXPERIMENTAL PROCEDURES
Plasmids and Cell Lines
RECQ1 site-directed mutagenesis was performed using pFastBac-RECQ1
as template by Loftstrand Lab. RECQ1 cDNAs were cloned into pFLAG-
CMV-2 expression vector from Sigma. HeLa cells were from ATCC. pGFP-
RPA expression plasmids were kindly provided by Dr. M. Wold (University of
Iowa).
Recombinant Proteins
Full-length His-tagged RECQ1 recombinant proteins were purified as
described in Supplemental Experimental Procedures.
Size Exclusion Chromatography
Size exclusion chromatography was performed with purified RECQ1 proteins
using a 24 ml Superdex 200 size exclusion column (GE Healthcare) by AKTA
FPLC (GE Healthcare; Supplemental Experimental Procedures).
DNA Substrates
The 19-bp forked duplex and HJ(X12) DNA substrates were prepared as
described [8]. Mobile D loops and open three-stranded DNA substrates
were prepared by sequential annealing [25] (Supplemental Experimental
Procedures).
DNA Helicase and BM Assays
DNA helicase [8] and BM assays for HJ [8], three-stranded open [25], and D
loop [25] DNA substrates were as described.
DNA Binding and Strand Annealing Assays
DNA binding and strand annealing assays were as previously described [8].
ATP Hydrolysis Assays
ATP hydrolysis was measured using [g-32P] ATP (PerkinElmer Life Sciences)
and analyzed by thin-layer chromatography on polyethyleneimine-cellulose
plates (Mallinckrodt Baker; Supplemental Experimental Procedures).
DNA Spreading
Replication track analyses were performed as described in Supplemental
Experimental Procedures.
Immunostaining
Immunostaining of transfected cells treated was performed as described in
Supplemental Experimental Procedures.
Survival Assays
Cell viability assays were performed using WST-1 reagent (Roche) according
to manufacturer’s protocol.
Chromatin Fractionation
Chromatin fractionation was performed using the Subcellular Protein Fraction-
ation Kit for Cultured Cells (Thermo Scientific) according to manufacturer’s
protocol. Western blots were done using antibodies against RECQ1 (Santa
Cruz Biotechnology), Topoisomerase I (BD Biosciences), and Histone H3
(Abcam).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.cub.2015.09.026.(F) Western blot showing Chk1 S345 phosphorylation in untreated and CPT-trea
either ALmutant RECQ1-expressing construct. CPT-treated RECQ1-W227A- and
Chk1S345, respectively, compared to CPT-treated cells that were transfected w
(G) Representative fluorescence images from 53BP1 staining of indicated cell lin
(H) Quantitative analysis of immunofluorescence data as shown in (G). Percenta
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